To examine the incidence of seizures and status epilepticus in brain tumor patients during the last 45 days of life, highlighting the significance of this critical period.
Key Findings:
72.3% of patients received a routine EEG within 45 days prior to death, indicating a proactive approach to monitoring; 58.8% of included patients had a primary brain tumor, suggesting a higher risk in this group; Patients presented an average of 16.8 days prior to death, with seizures being a common reason for admission, underscoring the need for timely intervention.
Interpretation:
The study suggests a high incidence of seizures and status epilepticus in brain tumor patients at the end of life, indicating a need for better recognition and management.
Limitations:
Retrospective design may limit the comprehensiveness of data, and the lack of statistical analysis due to the descriptive nature of the study may affect the robustness of the findings; potential bias in patient selection and reporting of seizures should be considered when interpreting results.
Conclusion:
The findings highlight the significant burden of seizures in brain tumor patients nearing the end of life, warranting further investigation and improved clinical practices to enhance patient care.
